3386.T
COSMO BIO COMPANY,LIMITED
スタンダード · 卸売業 · 商社・卸売 · JP
JPY 1,251.00
−0.32%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 11.0B | 10.8B | 10.0B | 9.3B | 9.6B |
| Cost of Revenue | 2.2B | 7.1B | 6.7B | 6.1B | 6.1B |
| Gross Profit | 1.1B | 3.7B | 3.3B | 3.2B | 3.4B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 864.0M | 3.4B | 3.0B | 2.7B | 2.6B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 864.0M | 3.4B | 3.0B | 2.7B | 2.6B |
| Cost and Expenses | 10.7B | 10.4B | 9.7B | 8.8B | 8.7B |
| Operating Income (EBIT) | 341.0M | 343.0M | 318.0M | 519.0M | 816.0M |
| Non-Operating | |||||
| Interest Income | 5.0M | 6.0M | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 5.0M | 6.0M | — | — | — |
| Other Non-Op Income/Expense | (6.0M) | 146.0M | 46.0M | 134.0M | (26.0M) |
| Non-Operating Income (excl Interest) | 11.0M | 152.0M | 86.0M | 136.0M | 57.0M |
| EBT (Pre-Tax Income) | 335.0M | 504.0M | 369.0M | 653.0M | 790.0M |
| Income Tax Expense | 102.0M | 170.0M | 99.0M | 191.0M | 238.0M |
| Bottom Line | |||||
| Net Income | 347.0M | 337.0M | 262.0M | 442.0M | 517.0M |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 347.0M | 337.0M | 262.0M | 442.0M | 517.0M |
| Per Share | |||||
| Basic EPS | ¥61 | ¥59 | ¥45 | ¥76 | ¥89 |
| Diluted EPS | ¥61 | — | — | — | — |
| Revenue Per Share | ¥1,940 | ¥1,893 | ¥1,726 | ¥1,602 | ¥1,646 |
| Shares | |||||
| Basic Shares Outstanding | 5.7M | 5.7M | 5.8M | 5.8M | 5.8M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | 510.0M | 454.0M | 667.0M | 957.0M |
| D&A | — | 167.0M | 136.0M | 148.0M | 141.0M |
| EBIT | 341.0M | 343.0M | 318.0M | 519.0M | 816.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026